What changed between revision 1 and revision 2, compared over the article's markdown source with its frontmatter — so a change to status, evidence or reversibility shows up as the edit it is.
Older · revision 1
Import· initial corpus import, not an edit
Initial import of content/robert-freitas.md — the filesystem corpus, unchanged. Not an edit.
11.8 kB
Revision 1
Revision 2
lines 7–13 → 7–136 unchanged lines not shown
categories: ["people", "nanomedicine"]categories: ["people", "nanomedicine"]tags: ["nanotechnology", "nanomedicine", "nanorobots", "molecular manufacturing", "self-replication", "cryonics"]tags: ["nanotechnology", "nanomedicine", "nanorobots", "molecular manufacturing", "self-replication", "cryonics"]summary: "American researcher whose Nanomedicine volumes set out detailed numerical designs for medical nanorobots, among them the respirocyte, none of which has been fabricated."summary: "American researcher whose Nanomedicine volumes set out detailed numerical designs for medical nanorobots, among them the respirocyte, none of which has been fabricated."updated: "2026-07-28"updated: "2026-10-29"------ ```infobox```infoboxlines 37–56 → 37–5623 unchanged lines not shown
## Overview## Overview Freitas works in a genre he calls exploratory engineering: analysis intended to establish that aFreitas works in a genre he calls exploratory engineering: analysis intended to establish that aproposed device violates no physical law and to bound its performance if built, deliberately settingproposed device violates no physical law and to bound its performance if built, while deliberatelyaside how anyone would build it. The output is a specification and a set of numbers rather than ansetting aside how anyone would build it. The output is a specification and a set of numbers ratherexperiment. Judged as engineering analysis the volumes are unusually thorough; judged as evidence thatthan an experiment. As engineering analysis the volumes are unusually thorough. As evidence that[[medical-nanorobots]] are coming, they establish nothing, because a design consistent with physics is[[medical-nanorobots]] are coming they establish nothing, because a design can be consistent withnot the same as a design that can be made. Most of the argument about his work is an argument aboutphysics and still impossible to make. Most of the argument about his work comes down to which ofwhich of those two things it is being read as.the two it is being read as. ## Career## Career Freitas took degrees in physics and psychology at Harvey Mudd College and a law degree at Santa ClaraFreitas took degrees in physics and psychology at Harvey Mudd College and a law degree at Santa ClaraUniversity. His early work was in exobiology rather than medicine: a long treatise on the scientificUniversity. His early work was in exobiology rather than medicine: a long treatise on the scientificstudy of extraterrestrial life and civilization, written in the 1970s, and a proposed scale rankingstudy of extraterrestrial life and civilization, written in the 1970s, and a proposed scale rankinginformation-processing systems by their rate of computation per unit mass. With William Gilbreath he co-editedinformation-processing systems by their rate of computation per unit mass. With William Gilbreath hethe report of the 1980 NASA/ASEE summer study on advanced automation for space missions, whose mostco-edited the report of the 1980 NASA/ASEE summer study on advanced automation for space missions, whose mostdiscussed section is a design for a self-replicating lunar factory.[^nasa1982]discussed section is a design for a self-replicating lunar factory.[^nasa1982] He began the *Nanomedicine* series in the mid-1990s at the Institute for Molecular Manufacturing inHe began the *Nanomedicine* series in the mid-1990s at the Institute for Molecular Manufacturing inlines 61–69 → 61–694 unchanged lines not shown
Volume I sets out basic capabilities: how a micron-scale device would draw power from blood glucose,Volume I sets out basic capabilities: how a micron-scale device would draw power from blood glucose,shed waste heat without cooking the tissue around it, know where it is, and talk to itsshed waste heat without cooking the tissue around it, know where it is, and talk to itsneighbours.[^freitas1999] Volume IIA is devoted entirely to biocompatibility — what the immune system,neighbours.[^freitas1999] Volume IIA is devoted entirely to biocompatibility: what the immune system,the complement cascade and the protein corona that coats anything injected into blood would do to a rigidthe complement cascade and the protein corona that coats anything injected into blood would do to adiamondoid object, and what surface chemistry might reduce it.[^freitas2003] Volumes IIB and III haverigid diamondoid object, and what surface chemistry might reduce it.[^freitas2003] Volumes IIB and III havebeen announced for many years and have not appeared.been announced for many years and have not appeared. The device studies are the part of the work that circulates. The 1998 respirocyte paper describes aThe device studies are the part of the work that circulates. The 1998 respirocyte paper describes alines 77–84 → 77–847 unchanged lines not shown
> [!note] What the numbers are> [!note] What the numbers are> Figures such as a respirocyte's oxygen-carrying advantage over a red cell are outputs of a physical> Figures such as a respirocyte's oxygen-carrying advantage over a red cell are outputs of a physical> model of a specified object. They are neither measurements nor forecasts, and they carry no> model of a specified object. They are neither measurements nor forecasts, and they carry no> information about when or whether the object could be made. The distinction is stated plainly in the> information about when or whether the object could be made. The papers themselves state this> papers themselves and lost in most secondary accounts of them.> plainly; most secondary accounts of them lose it. ## Self-replication and global ecophagy## Self-replication and global ecophagy lines 88–100 → 88–1003 unchanged lines not shown
it.[^ksrm2004]it.[^ksrm2004] That interest produced the most-cited thing he has written outside the medical designs. His 2000That interest produced the most-cited thing he has written outside the medical designs. His 2000analysis of global ecophagy asked what would physically limit a runaway population of biomass-consuminganalysis of global ecophagy asked what would physically limit a runaway population ofreplicators — the [[grey-goo]] scenario — and concluded that waste heat binds before materials do:biomass-consuming replicators (the [[grey-goo]] scenario) and concluded that waste heat binds beforeconverting the biosphere at the rates the scenario requires would release enough energy to destroy thematerials do: converting the biosphere at the rates the scenario requires would release enough energy to destroy themachinery doing it, and would produce a thermal signature detectable long beforehand. He treated this asmachinery doing it, and would produce a thermal signature detectable long beforehand. He treated this asgrounds for monitoring and for design restrictions on replicating systems rather than forgrounds for monitoring and for design restrictions on replicating systems rather than fordismissal.[^freitas2000] It is a rare case of a technology's proponent producing the quantitative riskdismissal.[^freitas2000] It is a rare case of a technology's proponent producing the quantitative riskanalysis, and it is cited in the [[existential-risk]] literature by people who reject the rest of theanalysis himself, and it is cited in the [[existential-risk]] literature by people who reject the rest of theprogramme.programme. ## Diamond mechanosynthesis## Diamond mechanosynthesislines 109–116 → 109–1168 unchanged lines not shown
evaluated with quantum-chemistry methods, and the two have coordinated a loose collaboration aimed at aevaluated with quantum-chemistry methods, and the two have coordinated a loose collaboration aimed at afirst experimental demonstration. A patent covering a tool for positional diamond mechanosynthesisfirst experimental demonstration. A patent covering a tool for positional diamond mechanosynthesisissued in 2010, and the 2009 Feynman Prize for theory recognized the tooltip work. No experimentalissued in 2010, and the 2009 Feynman Prize for theory recognized the tooltip work. No experimentaldemonstration of controlled diamond mechanosynthesis has been reported, which is the same gap that hasdemonstration of controlled diamond mechanosynthesis has been reported. The gap is the same one thatstood open since Richard Smalley's objections to Drexler in the early 2000s.has stood open since Richard Smalley's objections to Drexler in the early 2000s. ## Cryonics## Cryonics lines 120–152 → 120–1533 unchanged lines not shown
to perform.[^cryostasis2022] It is the fullest statement of the biological revival route described underto perform.[^cryostasis2022] It is the fullest statement of the biological revival route described under[[cryonics]], and it inherits that route's dependence on machinery nobody has built. That dependence is[[cryonics]], and it inherits that route's dependence on machinery nobody has built. That dependence ispart of why others in the field prefer the informational route, in which the preserved brain is scannedpart of why others in the field prefer the informational route, in which the preserved brain is scannedrather than repaired: the programme pursued under [[brain-preservation]] andrather than repaired; that programme is pursued under [[brain-preservation]] and[[whole-brain-emulation]]. [[alcor|Alcor]]'s own literature endorses neither route.[[whole-brain-emulation]]. [[alcor|Alcor]]'s own literature endorses neither route. > [!debate] Whether the analysis can be checked> [!debate] Whether the analysis can be checked> Supporters hold that a quantitative design that survives physical scrutiny is a stronger claim than> Supporters hold that a quantitative design that survives physical scrutiny is a stronger claim than> an assertion that revival is impossible, and that the burden has not been met on the other side.> an assertion that revival is impossible, and that the burden has not been met on the other side.> Critics hold that an analysis of surfaces, tissues and failure modes that have never been produced> Critics hold that an analysis of surfaces, tissues and failure modes that have never been produced> cannot be checked at all, and that unfalsifiable engineering is not engineering.> cannot be checked at all, and that engineering which cannot be falsified does not count as> engineering. ## Reception and legacy## Reception and legacy Chemists and clinical researchers have largely not engaged with the programme. The medical successes atChemists and clinical researchers have largely not engaged with the programme. The medical successes atthe nanoscale arrived by other routes entirely: [[lipid-nanoparticles]] and antibody conjugates fromthe nanoscale arrived by other routes entirely: [[lipid-nanoparticles]] and antibody conjugates fromformulation chemistry and immunology, [[dna-nanotechnology|DNA origami]] devices with no onboard power orformulation chemistry and immunology, [[dna-nanotechnology|DNA origami]] devices with no onboard power orcomputation, [[microrobots-in-medicine|magnetically steered particles]] that are steered from outsidecomputation, and [[microrobots-in-medicine|magnetically steered particles]] that are steered fromrather than autonomous. Freitas is cited far more in futurist, transhumanist and cryonics writing thanoutside rather than autonomous. Freitas is cited far more in futurist, transhumanist and cryonics writing thanin the clinical [[targeted-drug-delivery]] literature, and a substantial part of his outputin the clinical [[targeted-drug-delivery]] literature, and a substantial part of his outputappeared in books from a small press, in institute reports, or in journals associated with the movementappeared in books from a small press, in institute reports, or in journals associated with the movementrather than in mainstream biomedical venues.rather than in mainstream biomedical venues. The case for the work is that it is specific enough to be wrong. It names dimensions, materials, powerThe case for the work is that it is specific enough to be wrong. It names dimensions, materials,budgets and cycle times, which is more than most speculation about medicine's future offers, and thepower budgets and cycle times, which is more than most speculation about medicine's future offers,biocompatibility volume takes the strongest objections seriously instead of waving at them. The caseand the biocompatibility volume takes the strongest objections seriously instead of waving at them.against is that specificity about an object nobody can make is not the same as evidence, and thatThe case against is that specificity about an object nobody can make does not amount to evidence,thirty years of increasingly detailed designs with no fabrication attempt is the signature of a researchand that thirty years of increasingly detailed designs with no fabrication attempt is the signatureprogramme that has substituted analysis for experiment. Both readings survive the record as it stands,of a research programme that has substituted analysis for experiment. Both readings survive thewhich is why the argument has not moved much since *Nanomedicine* Volume I appeared.record as it stands, so the argument has not moved much since *Nanomedicine* Volume I appeared. ## See also## See also removed, struck through added, underlinedLine numbers count the serialised markdown of each revision, frontmatter included.
141 lines are the same in both revisions, and 74 of them are not shown. Neither revision here is necessarily the current article — read Robert Freitas for the text this wiki stands behind today.